Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Janssen Pharmaceutica, part of the Johnson & Johnson group has announced it will cut up from 125 to 148 jobs from its 5,309 employees. The restructuring, driven by the upcoming 2025 expiration of the Stelara patent (an anti-inflammatory) as well as rising costs in the pharmaceutical sector, aims to secure future profits for the facility. While no job losses are expected in the logistics department, other divisions may be affected. This concerns support services such as finance, marketing, administration, HR, research and development.
Unions have expressed their concern, noting the company’s profitability, but acknowledging the global nature of the restructuring efforts. Johnson & Johnson promises to support all employees such as providing retraining, so that they are also eligible for other jobs.
Eurofound (2024), Janssen Pharmaceutica, Internal restructuring in Belgium, factsheet number 201655, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/201655.